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Abstract
Environmental exposure to heavy metals is a potentially modifiable risk factor for pre-
eclampsia (PE). Toxicologically, there are known interactions between the toxic metal cad-
mium (Cd) and essential metals such as selenium (Se) and zinc (Zn), as these metals can
protect against the toxicity of Cd. As they relate to preeclampsia, the interaction between
Cd and these essential metals is unknown. The aims of the present study were to measure
placental levels of Cd, Se, and Zn in a cohort of 172 pregnant women from across the south-
east US and to examine associations of metals levels with the odds of PE in a nested case-
control design. Logistic regressions were performed to assess odds ratios (OR) for PE
with exposure to Cd controlling for confounders, as well as interactive models with Se or Zn.
The mean placental Cd level was 3.6 ng/g, ranging from 0.52 to 14.5 ng/g. There was an
increased odds ratio for PE in relationship to placental levels of Cd (OR = 1.5; 95% CI: 1.1–
2.2). The Cd-associated OR for PE increased when analyzed in relationship to lower pla-
cental Se levels (OR = 2.0; 95% CI: 1.1–3.5) and decreased with higher placental Se levels
(OR = 0.98; 95% CI: 0.5–1.9). Similarly, under conditions of lower placental Zn, the Cd-
associated OR for PE was elevated (OR = 1.8; 95% CI: 0.8–3.9), whereas with higher pla-
cental Zn it was reduced (OR = 1.3; 95% CI: 0.8–2.0). Data from this pilot study suggest that
essential metals may play an important role in reducing the odds of Cd-associated pre-
eclampsia and that replication in a larger cohort is warranted.
Introduction
Cadmium (Cd) is a ubiquitous toxic metal currently ranked 7th on the priority List of Hazard-
ous Substances by the Agency for Toxic Substances and Disease Registry [1]. Industrial activity
such as non-ferrous metal mining and refining, manufacturing and application of phosphate
fertilizers, fossil fuel combustion, and waste increases Cd leaching into the soil/water/air/food
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[2]. Cd can contaminate the soil/water/air/food by disposal of consumer products such as bat-
teries, pigments, coatings, and plastics. Another source of Cd exposure is via cigarette smoke
[2].
Chronic Cd exposure is associated with renal disease, hypertension, and cancer [3]. Cd
exposure during pregnancy has the potential to harm both the mother and fetus, as the pla-
centa does not serve as a complete barrier against Cd [4]. In support of this, maternal serum
Cd levels are significantly associated with umbilical and neonatal Cd levels highlighting the
transfer of this toxic metal to the fetus [5–7]. In utero exposure to Cd is associated with low
birth weight, decreased neonatal length and head circumference, and impaired childhood neu-
robehavioral and physiological development [8]. In addition, mean placental levels of Cd have
been shown to be higher in preeclamptics versus normotensive women [9]. However, the rela-
tionship between placental Cd levels and risk for preeclampsia is currently unknown.
There are known interactions between Cd and essential metals such as zinc (Zn) and sele-
nium (Se). Specifically, Zn and Se are both anti-oxidants that protect against Cd-induced toxic-
ity [10]. Also, increased placental Cd concentrations may impair essential elements such as Se
and Zn transfer to the fetus [4]. This is of concern as Zn deficiency is associated with fetal
growth restriction and neurodevelopment abnormalities [11, 12]. Furthermore, maternal Zn
deficiency has been associated with preeclampsia [13]. Women with preeclampsia have been
shown to have lower levels of Se compared to normotensive women [14–16]. The relationship
between Cd, Se, and Zn levels in the placenta as they relate to of risk of preeclampsia is not
known.
The aims of the present study were to measure placental Cd, Se, and Zn levels using samples
from a pregnancy cohort representing women across the southeastern US and to examine asso-
ciations of placental metal levels with the risk of preeclampsia. Biomonitoring of maternal
exposure to metals will potentially help to reduce prenatal exposures to toxic metals and inform
nutritional supplementation of essential metals, ultimately reducing future adverse pregnancy
complications and birth outcomes.
Materials and Methods
Study Population
This study is a nested case-control study within the Maternal Oral Therapy to Reduce Obstetric
Risk (MOTOR) study. This study was approved by the University of North Carolina, Chapel
Hill Institutional Review Board. The MOTOR cohort was a randomized, treatment-masked,
controlled clinical trial of 1,806 pregnant women with periodontal disease who were receiving
standard obstetric care (ClinicalTrials.gov Identifier: NCT00097656) [17]. Written consent
was obtained from all participants. The cohort has been fully described previously [17]. Briefly,
from December 2003 through October 2007 subjects were enrolled at Duke University Medical
Center (and the affiliated clinic at Lincoln Health Center), the University of Alabama at Bir-
minghamMedical Center, and two obstetric sites of the University of Texas Health Science
Center at San Antonio (University Health Center-Downtown of University Health Systems
and Salinas Clinic of the San Antonio Metropolitan Health District). Randomization occurred
between February 2004 and September 2007.
For this nested case-control study, 172 subjects were selected; 86 with preeclampsia and 86
healthy, normotensive women. Preeclampsia was defined using criteria current at the time of
the original study [18] as newly diagnosed hypertension (blood pressure>140/90 mmHg on
two occasions 6 hours apart) and proteinuria (>300 mg of protein in a 24 h urine collection or
urine protein/creatinine ratio of 0.3 mg/dL) occurring at> 20 weeks’ gestation. Controls were
randomly chosen among those without preeclampsia. Baseline maternal characteristics such as
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education, socioeconomic status (SES), and age, amongst others did not differ between the
nested cohort and the parent cohort (data not shown).
Placental Collection and Metals Measurements
Immediately after placental delivery, a single, full-thickness biopsy of the placenta was obtained
and flash-frozen. Biopsies were taken from the central zone of the placenta and standardized
across all samples as previously described [17]. Abnormal gross placental pathology (i.e.
infarcted areas) was avoided. Harvested placental tissues were stored at -70°C.
Placenta samples (169.7 ± 33.1 mg) were digested with 70% nitric acid at room temperature
for five hours before being placed in an 85 degree heating block overnight. After cooling to
room temperature, 30% hydrogen peroxide was added and the samples were returned to the
heating block. The vials were removed, cooled, and vented every twenty minutes for the first
hour. Digestion continued for an additional four hours and was complete after 24 hours. The
samples were then were diluted to 4 mL with deionized water. The determination of total Cd,
Se, and Zn was performed using the Agilent Technologies 7500cx inductively coupled plasma
mass spectrometer (ICP-MS), (Santa Clara, CA. USA). Analytes were quantified using pub-
lished protocols [19]. Cd and Zn isotopes measured were 111m/z and 66m/z respectively.
External calibration and quality control standards were prepared from National Institute Stan-
dards Technology (NIST) traceable solutions (High Purity Standards, Charleston, SC. USA).
The detection limit reported was corrected for dilution and normalized to a typical sample
mass of 0.150g. The limit of detection for the metals was: 1.5 ng/g (Cd), 1.5 ng/g (Se), and
300 ng/g (Zn).
Statistical Analyses
The statistical package SAS 9.4 (SAS Institute Inc., Cary, North Carolina) was used to analyze
the data. Spearman rank correlations were calculated to measure the inter-relationship among
placental metals levels and were considered to be significantly correlated if p<0.05. Chi Square
tests for differences in proportions of demographic variables between normotensives and pree-
clamptics were carried out; significance was set at p<0.05. Difference of means tests calculated
for demographic variables were performed using a two-sided Student’s t-test with significance
set at p<0.05. Wilcoxon rank sum tests were utilized to determine differences in the levels of
Cd, Se, and Zn between normotensives and preeclamptics with significance set at p<0.05. To
determine if Cd levels differed based on women’s self-reported smoking status for both pre
pregnancy and during pregnancy smoking a Wilcoxon rank sum tests was performed. Uncon-
ditional logistic regressions were performed accessing odd ratios (OR) and 95% Confidence
Intervals (CI) for PE with exposure to Cd (as a continuous variable) controlling for confound-
ers, as well as interactive models of Cd x Se and Cd x Zn. Confounders were selected a priori
based on their known associations with both the exposure (metals) and preeclampsia. Model 1
represents the unadjusted model without the inclusion of confounders. Model 2 included the
following covariates: correlated metals (continuous variable), and demographic variables col-
lected from in person questionnaires including, maternal age (continuous variable), education
(trichotomized), race (dichotomized), tobacco and alcohol use during pregnancy (dichoto-
mized as yes/no), public assistance recipient (dichotomized as yes/no as proxy of SES), gesta-
tional age (continuous variable), previous pregnancies (dichotomized as 0/>1), magnesium
sulfate treatment (yes/no), and periodontal disease treatment (dichotomized as pre or post-
delivery). For sensitivity analyses, two additional models were run as a variation of Model 2.
Model 3 excluded gestational age as a covariate and Model 4 excluded periodontal disease
treatment as a covariate. Interactive models of Cd x Se and Cd x Zn included an interaction
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term for Cd (continuous) x Se (dichotomized based on median levels of Se) and Cd (continu-
ous) x Zn (dichotomized based on median levels of Zn). Interaction term significance was set
at p<0.05. ORs were determined to be significant if the 95% CI did not include the null value
of 1.
Results
Characteristics of the Nested Case-Control Study
Maternal and birth characteristics for the nested case-control study are presented in Table 1.
The average age at delivery for all women was 25 years with 38% of the women self-identified
as white and 62% as black. Most of the women had a high school education or greater (85%),
received public assistance (73%), and reported no tobacco use during pregnancy (96%)
(Table 1).
Placental Metals Levels
No metal levels were below the detection limit. The mean placental Cd level was 3.6 ng/g
(median: 3.0; range: 0.52–14.5 ng/g; SD = 2.0). Mean placental Cd levels were higher among
cases compared to controls (3.7 ng/g versus 3.5 ng/g, p = 0.44). The mean placental Se level was
246.4 ng/g (median: 248.4; range: 90.2–514.3 ng/g; SD = 89.7) with Se levels lower among cases
compared to controls (237.5 ng/g versus 254.5 ng/g, p = 0.19). The mean placental Zn level was
8659.1 ng/g, (median: 8525.2; range: 3595.2–18573.9 ng/g; SD = 2105.6). Mean placental Zn
levels were significantly higher in cases compared to controls (8892.0 ng/g versus 8414.7 ng/g,
p = .04). Placental Cd and Se levels were both significantly correlated with placental Zn levels
(p<0.001 and p< .05, respectively) (Table 2). In relationship to smoking status, placental Cd
levels were slightly higher in smokers than in non-smokers but not statistically significant. The
lack of significant difference may suggest other potential environmental sources for Cd (S1
Table).
Odds Ratios of PE in Relationship to Cd, Zn and Se
The adjusted odds ratio (Model 2) for PE in relationship to placental Cd levels was 1.5 (95%
CI: 1.1–2.2) (Table 3). The interaction terms of both Cd x Se, and Cd x Zn were significant
(p<0.05). ORs for PE in relationship to Cd were assessed in relationship to lower or higher Zn
or Se based on their median values of 8669 ng/g and 246 ng/g respectively. When an interaction
term was included in the model for Cd x Zn, the OR for PE in relationship to placental Cd lev-
els in placentas with lower Zn levels was 1.8 (95% CI: 0.8–3.9). In contrast, the OR for PE in
placentas with higher Zn levels was 1.3 (95% CI: 0.8–2.0) (Table 3). When an interaction term
was included in the model for Cd x Se, the OR for PE in relationship to elevated placental Cd
level for placentas with lower Se levels was 2.0 (95% CI: 1.1–3.5). This differed from the OR for
PE in relationship to higher Se calculated to be 0.98 (95% CI: 0.5–1.9) (Table 3). As gestational
age may be a mediator of the relationship between Cd exposure and PE a sensitivity analysis
(Model 3) excluding gestational age was carried out. The results demonstrated a reduction in
the ORs of PE (S2 Table). As this study is a nested case-control within the MOTOR cohort
with a focus on periodontal disease, a sensitivity analysis (Model 4) excluding periodontal dis-
ease treatment was assessed. The results demonstrated no change in the ORs (S2 Table). The
minimal dataset used for analysis is provided (S1 Data).
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Table 1. Demographic Characteristics of the Nested Case-Control Study Participants.
Characteristic Mean, Median [Range] or n (%)




Chi Square test statistic or
T-Test (p-value)
Maternal Age at Delivery
(years)
25, 24 [16–41] 25, 24 [16–41] 24, 23 [16–40] (0.16)
Race
White 66 (38) 33 (38) 33 (38)
Black 106 (62) 53 (62) 53 (62) 0 (1)
Education
< High School 25 (15) 13 (15) 12 (14)
High School 109 (63) 53 (62) 56 (65)
> High School 38 (22) 20 (23) 28 (21) 0.23 (0.89)
Receiving government
assistance
No 46 (24) 30 (35) 16 (19)
Yes 126 (73) 56 (65) 70 (81) 5.8 (0.015)
Smoking during pregnancy
Non-smoker 156 (96) 75 (95) 81 (98)
Smoker 6 (4) 4 (5) 2 (2) 0.87 (0.34)
Smoking pre-pregnancy
Non-smoker 145 (84) 73 (85) 72 (84)
Smoker 27 (16) 13 (15) 14 (16) 0.044 (0.83)
Alcohol Consumption
None 167 (97) 84 (98) 83 (97)
Some 5 (3) 2 (2) 3 (3) 0.21 (0.64)
Method of Delivery
Vaginal 115 (67) 58 (67) 57 (66)
Caesarean section 57 (33) 28 (33) 29 (34) 0.026 (0.87)
Gestational Age (weeks)
All 39, 39 [26–42] 40, 40 [37–42] 38, 38 [26–42] (<0.001)
<37 weeks 23 (13) 0 (0) 23 (27)
37 weeks 149 (87) 86 (100) 63 (73) 26.6 (<0.001)
Newborn sex
Male 93 (54) 51 (60) 42 (49)
Female 79 (46) 35 (40) 44 (51) 1.9 (0.16)
Birth weight (g) 3205, 3195[760–
4940]
3420, 3335 [2515–4495] 2997, 2966[760–4940] (<0.001)
Low Birth Weight (LBW) 17 (10) 0 (0) 17 (20)
Newborn Length (cm) 50, 50 [33–57] 50, 51 [33–57] 49, 49 [33–55] (0.0014)
Head Circumference (cm) 34, 34 [24–49] 34, 34 [31–49] 33, 34 [24–48] (0.0130)
Fetal Congenital
Abnormalities
7 (4) 5 (6) 2 (2) 1.3 (0.24)
Previous Pregnancies
0 42 (24) 14 (16) 28 (33)
1 130 (76) 72 (84) 58 (67) 6.2 (0.013)
doi:10.1371/journal.pone.0139341.t001
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Discussion
The placenta represents a unique temporary organ for the measurement of toxic and essential
metals. It serves as the interface between fetal and maternal circulation facilitating the exchange
of gases and transport of nutrients, but also as a potential source for fetal exposure to environ-
mental contaminants such as Cd. It is currently unknown whether placental Cd levels are asso-
ciated with risk for preeclampsia. In the present study we set out to establish whether Cd is
associated with an increased risk in samples collected from women residing in the Southeastern
US (Alabama, North Carolina, and Texas) using a nested case-control study design within the
MOTOR cohort. The mean level of placental Cd level was 3.6 ng/g and ranged from 0.52 ng/g
up to 14.5 ng/g. Supporting the broader relevance of the findings from this study, these placen-
tal levels are consistent with those observed both in the US as well as globally [20]. We found
that placental Cd levels are significantly associated with preeclampsia (OR = 1.5; 95% CI: 1.1–
2.2), highlighting the potential impact of toxic metal exposure on adverse pregnancy outcomes.
Table 2. Levels and correlations of placental metals in all subjects, normotensives (controls), and preeclamptics (cases); all values are reported
as ng/g wet weight.
All (n = 172) Controls (Normotensives) (n = 86) Cases (Preeclamptics) (n = 86)
Mean (Median) Range Mean (Median) Range Mean (Median) Range
Cd (ng/g) 3.6 (3.0) [0.52–14.5] 3.5 (3.1) [0.52–8.7] 3.7 (3.0) [0.84–14.5]
Se (ng/g) 246.4 (248.4) [90.2–514.3] 237.5 (208.2) [91.5–514.3] 254.5 (269.7) [90.2–445.6]
Zn (ng/g) 8659.1 (8525.2) [3595.2–18573.9] 8414.7 (8175.4) [3595.2–18573.9] 8892.0(8723.4)* [4825.0–16368.8]
Correlation Coefficient+ (p-value) Correlation Coefficient+ (p-value) Correlation Coefficient+ (p-value)
Cd—Zn 0.36 (p<0.001) 0.38 (p<0.001) 0.35 (p<0.001)
Cd—Se -0.067 (0.10) 0.081 (0.45) -0.20 (0.06)
Se—Zn 0.19 (0.04) 0.30 (0.04) 0.079 (0.47)
*p<0.05, Wilcoxon Rank Sum Test between cases and controls.
+ Spearman Rank Correlation Coefficient
doi:10.1371/journal.pone.0139341.t002
Table 3. Odds ratios and 95%Confidence Intervals (CI) for preeclampsia in relationship to placental
Cd, Se or Zn and interactive models for Cd with essential metals Se and Zn.
Unadjusted Odds Ratio (95% CI)a Odds Ratio (95% CI)b
Cd 1.1 (0.9–1.2) 1.5 (1.1–2.2)
Se 1.0 (0.99–1.0) 1.0 (0.99–1.0)
Zn 1.0 (1.0–1.0) 1.0 (1.0–1.0)
Cd x Se
Se  median level+ 1.1 (0.9–1.4) 2.0 (1.1–3.5)
Se > median level+ 0.98 (0.78–1.2) 0.98 (0.5–1.9)
Cd x Zn
Zn  median level ++ 0.97 (0.71–1.3) 1.8 (0.8–3.9)
Zn > median level ++ 1.0 (0.84–1.2) 1.3 (0.8–2.0)
aModel 1 represents the crude or unadjusted model.
bModel 2 correlated metals, maternal age, education, race, tobacco, alcohol use during pregnancy, public
assistance recipient, gestational age, previous pregnancies, magnesium sulfate treatment, and periodontal
disease treatment.
+Se median = 246 ng/g
++Zn median = 8669 ng/g
doi:10.1371/journal.pone.0139341.t003
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In addition to the measurement of Cd, we also examined placental levels of Se and Zn that
were found to be comparable to other US cohorts [4, 19]. Interestingly, when analyzed in the
context of placental Se and Zn levels the relationship between placental Cd exposure and pre-
eclampsia was altered. Placental Se levels below the median significantly increased the associa-
tion between placental Cd levels and preeclampsia resulting in an OR of 2.0 (95% CI: 1.1–3.5).
This was in contrast to the observed OR when placental Se levels were above the median of
0.98 (95% CI: 0.5–1.9). These data suggest that placental Se protects against Cd-associated PE.
Our findings contribute to a growing body of literature relating decreased maternal Se levels
with PE [14–16] and that Se supplementation may reduce PE risk [21]. While the CI intervals
included the null value for each level of Zn, the ORs indicate that lower placental Zn levels
increased the odds for PE (OR = 1.89; 95% CI: 0.8–3.9) compared to the OR for Cd alone
(OR = 1.5; 95% CI: 1.1–2.2). Our data compliment previous toxicologic studies that show Zn is
protective against Cd-mediated toxicity and that Zn deficiency increases Cd toxicity [22]. It
remains to be determined whether maternal serum or placental Zn insufficiency predisposes to
placental Cd toxicity and development of preeclampsia or if Cd toxicity impairs Zn transfer
and placental function leading to preeclampsia. This is the first study to demonstrate interac-
tive effects of both placental Se and Zn in relationship to Cd-associated PE.
Possible biological mechanisms for the relationship between Cd-associated PE and subse-
quent protection from Cd toxicity by Se and Zn are suggested through in vitro studies and ani-
mal models. One mechanism for Cd-associated PE may be through oxidative stress and/or
reactive oxygen species (ROS) as Cd induces both [23]. Oxidative stress, indicated by increased
ROS in the placenta, is known to be associated with impaired placental function, pregnancy
complications, and decreased size at birth [24–26]. Additionally, it has been suggested that the
protective role of Zn against Cd-induced toxicity may be through the reduction of Cd-induced
ROS [27]. The precise mechanisms by which Se and Zn protect against Cd-induced toxicity are
not established.
While our findings suggest that placental Cd levels are associated with PE and that Se may
be protective of such a relationship, there are potential limitations. These analyses are limited
to Cd, Se, and Zn and it is known that there are other toxic and essential metal interactions
that may influence Cd absorption and toxicity [28]. In relationship to smoking status, placental
Cd levels were slightly higher in smokers than in non-smokers but not statistically significant.
The lack of significant difference may suggest other potential environmental sources for Cd.
Still smoking status information was collected via self-report and measurements of cotinine
were not available. Additionally, while we have sufficient power to determine the risk of pre-
eclampsia with placental Cd levels, the sample size may limit strong conclusions based on
interactive models. Thus, to further support these findings replication in a larger cohort is
needed. While the current study uses a cross-sectional measurement of placental Cd, it is a suit-
able exposure indicator as it is a cumulative toxicant with a multi-year half-life in numerous
tissues [1]. Furthermore, measures of Cd in the placenta have been shown to correlate with lev-
els in both maternal blood and urine [4, 29]. The relationships between placental Se and Zn
and circulating levels of these essential metals are not established and should be analyzed in
future work.
In summary, this is the first study to address interactive effects of the toxic metal Cd and
essential metals in the placenta with odds of preeclampsia in a US cohort. Its strengths include
the measurement of placental metals levels as an exposure biomarker for both maternal and
fetal health. Such measures have been suggested as highly informative and practical application
in birth cohorts [20]. An additional benefit of this study is an examination of the interactions
between Cd, an environmental toxicant, and Se and Zn which are essential metals. Our data
suggest that the interaction between these metals may be more biologically relevant than
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studying single metals alone. Overall the results from this study suggest that Se and Zn may
play an important role in reducing the risk of Cd-associated preeclampsia. Future studies will
benefit from addressing the role of essential metals in reducing the risks of diseases during
pregnancy and the interplay with toxic metal exposure.
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